Cassava Historical Balance Sheet

SAVA Stock

USD 26.48 5.70 17.71%

Trend analysis of Cassava Sciences balance sheet accounts such as Accounts Payable of 11.1 M, Cash of 69.6 M, Non Current Assets Total of 23.1 M or Cash And Short Term Investments of 100.9 M provides information on Cassava Sciences' total assets, liabilities, and equity, which is the actual value of Cassava Sciences to its prevalent stockholders. By breaking down trends over time using Cassava Sciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cassava Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cassava Sciences is a good buy for the upcoming year.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.

About Cassava Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cassava Sciences at a specified time, usually calculated after every quarter, six months, or one year. Cassava Sciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cassava Sciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cassava currently owns. An asset can also be divided into two categories, current and non-current.

Cassava Sciences Balance Sheet Chart

At present, Cassava Sciences' Property Plant And Equipment Net is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 11.1 M, whereas Total Assets are forecasted to decline to about 114.4 M.

Total Assets Total Current Liabilities Total Stockholder Equity Property Plant And Equipment Net Net Debt

Add Fundamental

Total Assets

Total assets refers to the total amount of Cassava Sciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cassava Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cassava Sciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cassava Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most accounts from Cassava Sciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cassava Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.At present, Cassava Sciences' Property Plant And Equipment Net is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 11.1 M, whereas Total Assets are forecasted to decline to about 114.4 M.

	2021	2022	2023	2024 (projected)
Total Current Liabilities	12.5M	7.1M	14.2M	7.4M
Total Assets	266.8M	234.8M	151.7M	114.4M

Total Current Liabilities Total Assets

Cassava Sciences balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Other Current Liab	Non Currrent Assets Other	Current Deferred Revenue	Short Term Debt	Net Tangible Assets	Retained Earnings Total Equity
Total Assets		0.71	0.98	0.84	-0.99	-0.6	0.65	0.99	0.86	1.0	0.29	0.39	0.82	-0.01	0.92	0.83	0.25	0.82	1.0	0.77	0.88	0.8	-0.02	-0.23	0.85	-0.72
Total Current Liabilities	0.71		0.57	0.62	-0.67	-0.55	0.64	0.66	0.63	0.71	0.33	0.48	0.55	0.52	0.6	0.61	0.75	0.62	0.71	0.23	0.76	0.85	0.15	-0.15	0.62	-0.41
Total Stockholder Equity	0.98	0.57		0.83	-0.97	-0.57	0.61	0.98	0.84	0.97	0.25	0.32	0.82	-0.21	0.92	0.81	0.03	0.8	0.97	0.83	0.82	0.69	-0.08	-0.23	0.83	-0.74
Property Plant And Equipment Net	0.84	0.62	0.83		-0.85	-0.84	0.91	0.78	1.0	0.81	0.27	0.27	0.93	-0.25	0.97	0.95	0.13	1.0	0.83	0.51	0.91	0.67	-0.02	-0.18	0.98	-0.8
Net Debt	-0.99	-0.67	-0.97	-0.85		0.61	-0.66	-0.99	-0.86	-0.99	-0.29	-0.39	-0.84	0.05	-0.93	-0.84	-0.22	-0.82	-1.0	-0.79	-0.89	-0.8	0.05	0.24	-0.86	0.74
Retained Earnings	-0.6	-0.55	-0.57	-0.84	0.61		-0.86	-0.53	-0.83	-0.57	-0.61	-0.31	-0.89	0.19	-0.75	-0.94	-0.17	-0.86	-0.59	-0.27	-0.72	-0.56	0.36	0.5	-0.82	0.76
Accounts Payable	0.65	0.64	0.61	0.91	-0.66	-0.86		0.56	0.9	0.61	0.31	0.31	0.86	-0.21	0.81	0.88	0.2	0.92	0.63	0.19	0.88	0.59	-0.05	-0.19	0.92	-0.67
Cash	0.99	0.66	0.98	0.78	-0.99	-0.53	0.56		0.79	0.99	0.27	0.38	0.77	-0.03	0.88	0.77	0.19	0.75	0.99	0.82	0.83	0.77	-0.05	-0.23	0.79	-0.69
Non Current Assets Total	0.86	0.63	0.84	1.0	-0.86	-0.83	0.9	0.79		0.82	0.26	0.27	0.93	-0.24	0.98	0.95	0.14	1.0	0.84	0.53	0.92	0.68	-0.02	-0.18	0.98	-0.81
Cash And Short Term Investments	1.0	0.71	0.97	0.81	-0.99	-0.57	0.61	0.99	0.82		0.29	0.41	0.8	0.03	0.9	0.8	0.28	0.78	1.0	0.78	0.86	0.81	-0.03	-0.23	0.82	-0.7
Net Receivables	0.29	0.33	0.25	0.27	-0.29	-0.61	0.31	0.27	0.26	0.29		0.53	0.39	0.08	0.25	0.5	0.2	0.27	0.29	0.11	0.32	0.2	-0.87	-0.97	0.24	-0.27
Common Stock Total Equity	0.39	0.48	0.32	0.27	-0.39	-0.31	0.31	0.38	0.27	0.41	0.53		0.25	0.28	0.27	0.34	0.39	0.27	0.4	0.06	0.37	0.34	-0.3	-0.45	0.3	0.08
Common Stock Shares Outstanding	0.82	0.55	0.82	0.93	-0.84	-0.89	0.86	0.77	0.93	0.8	0.39	0.25		-0.3	0.91	0.98	0.07	0.93	0.81	0.6	0.84	0.7	-0.2	-0.33	0.95	-0.89
Non Current Liabilities Total	-0.01	0.52	-0.21	-0.25	0.05	0.19	-0.21	-0.03	-0.24	0.03	0.08	0.28	-0.3		-0.24	-0.23	0.91	-0.24	0.01	-0.22	-0.04	0.4	0.29	0.06	-0.26	0.3
Other Current Assets	0.92	0.6	0.92	0.97	-0.93	-0.75	0.81	0.88	0.98	0.9	0.25	0.27	0.91	-0.24		0.92	0.1	0.96	0.91	0.67	0.91	0.69	-0.03	-0.19	0.95	-0.82
Other Stockholder Equity	0.83	0.61	0.81	0.95	-0.84	-0.94	0.88	0.77	0.95	0.8	0.5	0.34	0.98	-0.23	0.92		0.15	0.95	0.82	0.52	0.87	0.68	-0.26	-0.42	0.95	-0.84
Total Liab	0.25	0.75	0.03	0.13	-0.22	-0.17	0.2	0.19	0.14	0.28	0.2	0.39	0.07	0.91	0.1	0.15		0.14	0.27	-0.13	0.32	0.63	0.27	-0.02	0.13	0.01
Property Plant And Equipment Gross	0.82	0.62	0.8	1.0	-0.82	-0.86	0.92	0.75	1.0	0.78	0.27	0.27	0.93	-0.24	0.96	0.95	0.14		0.8	0.46	0.9	0.66	-0.02	-0.18	0.98	-0.79
Total Current Assets	1.0	0.71	0.97	0.83	-1.0	-0.59	0.63	0.99	0.84	1.0	0.29	0.4	0.81	0.01	0.91	0.82	0.27	0.8		0.78	0.87	0.81	-0.03	-0.23	0.84	-0.71
Common Stock	0.77	0.23	0.83	0.51	-0.79	-0.27	0.19	0.82	0.53	0.78	0.11	0.06	0.6	-0.22	0.67	0.52	-0.13	0.46	0.78		0.48	0.53	-0.1	-0.17	0.5	-0.68
Other Current Liab	0.88	0.76	0.82	0.91	-0.89	-0.72	0.88	0.83	0.92	0.86	0.32	0.37	0.84	-0.04	0.91	0.87	0.32	0.9	0.87	0.48		0.75	-0.02	-0.22	0.91	-0.71
Non Currrent Assets Other	0.8	0.85	0.69	0.67	-0.8	-0.56	0.59	0.77	0.68	0.81	0.2	0.34	0.7	0.4	0.69	0.68	0.63	0.66	0.81	0.53	0.75		0.21	-0.05	0.7	-0.62
Current Deferred Revenue	-0.02	0.15	-0.08	-0.02	0.05	0.36	-0.05	-0.05	-0.02	-0.03	-0.87	-0.3	-0.2	0.29	-0.03	-0.26	0.27	-0.02	-0.03	-0.1	-0.02	0.21		0.95	0.0	0.14
Short Term Debt	-0.23	-0.15	-0.23	-0.18	0.24	0.5	-0.19	-0.23	-0.18	-0.23	-0.97	-0.45	-0.33	0.06	-0.19	-0.42	-0.02	-0.18	-0.23	-0.17	-0.22	-0.05	0.95		-0.15	0.24
Net Tangible Assets	0.85	0.62	0.83	0.98	-0.86	-0.82	0.92	0.79	0.98	0.82	0.24	0.3	0.95	-0.26	0.95	0.95	0.13	0.98	0.84	0.5	0.91	0.7	0.0	-0.15		-0.78
Retained Earnings Total Equity	-0.72	-0.41	-0.74	-0.8	0.74	0.76	-0.67	-0.69	-0.81	-0.7	-0.27	0.08	-0.89	0.3	-0.82	-0.84	0.01	-0.79	-0.71	-0.68	-0.71	-0.62	0.14	0.24	-0.78

Click cells to compare fundamentals

Cassava Sciences Account Relationship Matchups

Cassava Sciences balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	23.5M	94.3M	266.8M	234.8M	151.7M	114.4M
Total Current Liabilities	1.4M	1.9M	12.5M	7.1M	14.2M	7.4M
Total Stockholder Equity	22.1M	92.2M	253.9M	227.5M	137.5M	80.1M
Property Plant And Equipment Net	137K	306K	20.8M	23.0M	21.9M	22.9M
Net Debt	(23.0M)	(93.2M)	(233.2M)	(200.9M)	(121.1M)	(115.1M)
Retained Earnings	(168.6M)	(174.9M)	(207.3M)	(283.6M)	(380.8M)	(361.7M)
Accounts Payable	453K	911K	7.1M	4.0M	10.6M	11.1M
Cash	23.1M	93.5M	233.4M	201.0M	121.1M	69.6M
Non Current Assets Total	137K	306K	22.3M	23.6M	22.0M	23.1M
Cash And Short Term Investments	23.1M	93.5M	233.4M	201.0M	121.1M	100.9M
Common Stock Total Equity	7K	17K	22K	35K	40K	39.3K
Common Stock Shares Outstanding	17.4M	26.1M	39.4M	40.2M	41.9M	44.0M
Liabilities And Stockholders Equity	23.5M	94.3M	266.8M	234.8M	151.7M	114.4M
Non Current Liabilities Total	294K	543K	235K	333K	232K	0.0
Other Current Assets	268K	945K	11.0M	11.1M	7.5M	7.9M
Other Stockholder Equity	191.6M	267.1M	461.2M	511.0M	518.2M	544.1M
Total Liab	1.4M	2.1M	12.9M	7.3M	14.2M	24.9M
Property Plant And Equipment Gross	137K	11K	20.8M	23.0M	24.1M	25.3M
Total Current Assets	23.3M	94.0M	244.5M	211.2M	129.6M	110.4M
Common Stock	190.7M	267.1M	461.2M	511.1M	42K	39.9K
Other Current Liab	9K	838K	5.2M	2.8M	3.6M	3.8M
Non Currrent Assets Other	(1K)	90K	295K	399K	359.1K	305.9K
Net Tangible Assets	22.1M	92.2M	252.8M	226.9M	261.0M	274.0M
Retained Earnings Total Equity	(164.0M)	(168.6M)	(174.9M)	(207.3M)	(186.6M)	(195.9M)
Capital Surpluse	183.6M	190.7M	267.1M	461.2M	530.4M	556.9M
Property Plant Equipment	47K	306K	20.8M	23.0M	26.4M	27.8M
Net Invested Capital	22.1M	92.2M	253.9M	227.5M	137.5M	119.8M
Net Working Capital	22.0M	92.1M	231.9M	204.2M	115.4M	109.2M
Capital Stock	22K	35K	40K	42K	48.3K	36.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Cassava Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cassava Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cassava Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cassava Sciences Stock:

How To Invest In Cassava

Details

Is Cassava Stock a good investment?

Details

What is Cassava Sciences' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.

You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.38)

Return On Assets

(0.46)

Return On Equity

(0.11)

The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cassava Historical Balance Sheet

About Cassava Balance Sheet Analysis

Cassava Sciences Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Property Plant And Equipment Net

Net Debt

Cassava Sciences balance sheet Correlations

Cassava Sciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cassava Sciences balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Non Current Assets Total
Total Current Assets	+ 1.0	Cash And Short Term Investments

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Assets
Short Term Debt	- 0.97	Net Receivables
Net Debt	- 0.97	Total Stockholder Equity